Literature DB >> 912549

1alpha-Hydroxycholecalciferol in children with renal osteodystrophy.

R J Postlethwaite, I B Houston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 912549     DOI: 10.1007/bf02064103

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN: 0008-0594


× No keyword cloud information.
  6 in total

1.  1-Alpha-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure.

Authors:  T M Chalmers; J O Hunter; M W Davie; K F Szaz; B Pelc; E Kodicek
Journal:  Lancet       Date:  1973-09-29       Impact factor: 79.321

2.  Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.

Authors:  J L O'Riordan; J Page; D N Kerr; J Walls; J Moorhead; R E Crockett; H Franz; E Ritz
Journal:  Q J Med       Date:  1970-07

3.  Metabolic effects of 1alpha-hydroxycholecalciferol on renal osteodystrophy.

Authors:  S Castells; F Shai; B Gauthier; S E Hashemi; C M Reddy; H F De Luca
Journal:  Curr Ther Res Clin Exp       Date:  1976-03

4.  I alpha-hydroxycholecalciferol: a treatment of renal bone disease.

Authors:  G R Catto; M MacLeod; B Pelc; E Kodicek
Journal:  Br Med J       Date:  1975-01-04

5.  Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.

Authors:  A M Pierides; H A Ellis; W Simpson; J H Dewar; M K Ward; D N Kerr
Journal:  Lancet       Date:  1976-05-22       Impact factor: 79.321

6.  Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure.

Authors:  L Tougaard; E Sorensen; J Brochner-Mortensen; M S Christensen; P Rodbro; A W Sorensen
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.